1. Pink Sheet
  2. >>Geography
  3. >>Europe

EU Drafts Recommendations On Identifying Suitable RWD Sources For Studies

 
• By Vibha Sharma

EU regulators have developed a draft good practice guide explaining how stakeholders can make use of the Metadata Catalog of RWD Sources, which is expected to be released in late 2023, to identify appropriate sources for specific research questions.

Businessman searching for big data
Identification of appropriate RWD sources is becoming increasingly important for regulatory decision making • Source: Shutterstock

Regulators in the EU have issued draft recommendations explaining how drug companies and other stakeholders can identify suitable real-world data sources for studies, and what metadata elements they should consider for this purpose.

The recommendations are listed in a draft good practice guide jointly issued by the European Medicines Agency and the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

UK Budget: Little Mention Of Pharma, But Some Support For Innovators

 
• By Eliza Slawther

The UK’s autumn budget failed to introduce any widespread changes for pharma, but scale-ups and innovators could benefit from changes to enterprise and investment schemes. Some industry voices warn of underinvestment in the MHRA and innovative medicines.

Who Does What? EU RADIAL Study Exposes Oversight Challenges In Decentralized Trials

 
• By Vibha Sharma

Decentralizing clinical research demands rethinking accountability and logistics to prevent gaps that could compromise safety and trial integrity.

European Commission Dismisses Calls For Pause On Waste Water Directive

 
• By Anabel Costa-Ferreira

The European Commission says it will soon publish an updated study on the impact of the Urban Waste Water Treatment Directive on the pharmaceutical and cosmetics industry and that it would support member states in avoiding “unintended consequences.”

EU HTA Regulation Brings Alignment – But National ‘Recipes’ Still Rule Reimbursement

 
• By Eliza Slawther

While there is a general shift towards alignment and collaboration in health technology assessments in the EU under the new HTA Regulation, member states still have “their own recipe” when it comes to making reimbursement decisions.

More from Geography

Trump’s Semaglutide Most Favored Nation Price Will ‘Supersede’ Medicare MFP

 
• By Cathy Kelly

The Medicare negotiated price is slightly higher than the Most Favored Nation price recently announced by the Trump Administration.

AI Boosts Parkinson’s Disease Cell Therapy Development

 
• By Bridget Silverman

Aspen Neurosciences and BlueRock Therapeutics see hope for artificial intelligence to improve the quality of cell therapies to replace dopaminergic neurons in Parkinson's disease.

PhRMA Urges Japan To Maintain Drug Prices Amid MFN Concerns

 
• By Lisa Takagi

While Japan tries to balance its healthcare costs, the major US industry group is concerned reimbursement pricing practices in the country could influence US levels under Trump's MFN policy.